Gilead Sciences (GILD) Total Non-Current Liabilities (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Total Non-Current Liabilities data on file, last reported at $55.4 billion in Q1 2026.

• Quarterly Total Non-Current Liabilities changed 0.48% year-over-year to $55.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.4 billion (changed 0.48% YoY) and the FY2025 annual result came in at $57.9 billion, changed 0.27% from the prior year.
• Total Non-Current Liabilities declined to $55.4 billion in Q1 2026, from $57.9 billion in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $62.1 billion in Q1 2022 to a low of $52.8 billion in Q2 2024.
• A 5-year average of $58.0 billion and a median of $57.9 billion in 2025 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2024 — Total Non-Current Liabilities fell 13.35% — and 2025, when it gained 7.95%.
• Tracing GILD's Total Non-Current Liabilities over 5 years: stood at $62.0 billion in 2022, then slipped by 3.07% to $60.1 billion in 2023, then retreated by 3.97% to $57.7 billion in 2024, then gained by 0.27% to $57.9 billion in 2025, then retreated by 4.32% to $55.4 billion in 2026.
• The last three Total Non-Current Liabilities figures came in at $55.4 billion (Q1 2026), $57.9 billion (Q4 2025), and $57.4 billion (Q3 2025), per Business Quant data.